Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI) with currently
approved indications for the treatment of depression, obsessive‐compulsive disorder, panic …

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

Background Recognition is growing that social anxiety disorder (SAnD) is a chronic and
disabling disorder, and data from early trials demonstrate that medication may be effective in …

Placebo‐controlled trials have evaluated the efficacy of several medications in the treatment
of social anxiety disorder but information regarding their relative efficacy is lacking. We …

In this report, recommendations for the pharmacological treatment of anxiety and obsessive-
compulsive disorders are presented, based on available randomized, placebo-or …

Selection: Studies in patients with major depressive disorder, dysthymia, obsessive-
compulsive disorder, panic disorder, social anxiety disorder, generalised anxiety disorder or …

Background: This multicenter, double-blind, placebo-controlled study was carried out to
determine the effectiveness and safety of various daily dosages of paroxetine for the …

This review presents current literature on the epidemiology and treatment of social anxiety
disorder (social phobia). This illness has been demonstrated to be the most common anxiety …

Social Anxiety Disorder: A Common, Underrecognized Mental Disorder | AAFP Advertisement
search close brand logo TIMOTHY J. BRUCE, PH.D., AND SY ATEZAZ SAEED, MD Am Fam …